Corellation of Mutations, TILs and Age in Breast Cancer

Hellenic Cooperative Oncology Group

Status: Completed

Conditions: Breast Cancer

Treatments: Genetic: Corellation of Mutations, TILs and Age in Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04033965

HE10/mut

Details and patient eligibility

About

Age may pertain to different tumor genotype characteristics which may interfere with treatment efficacy and prognosis. The investigators investigated the distribution and prognostic effect of mutations (mut) and tumor infiltrating lymphocyte (TILs) in young and elderly early breast cancer patients (pts).

Enrollment: 345 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women with early breast cancer <35 years old or >65 years old

Exclusion criteria

• NA

Trial design

345 participants in 2 patient groups

women <35 with early breast cancer

Treatment:

Genetic: Corellation of Mutations, TILs and Age in Breast Cancer

women>65 years old with early breast cancer

Treatment:

Genetic: Corellation of Mutations, TILs and Age in Breast Cancer